Hologic, Inc. (NASDAQ:HOLX) Q2 2020 Earnings Conference Call April 29, 2020 4:30 PM ET Company Participants Michael Watts - VP, IR & Corporate Communications Stephen MacMillan - Chairman, CEO & President Karleen Oberton - CFO Conference Call Participants Tycho Peterson - JPMorgan Chase & Co. Patrick Donnelly - Citigroup Brian Weinstein - William Blair & Company Doug Schenkel - Cowen and Company Ivy Ma - Bank of America Merrill Lynch Anthony Petrone - Jefferies David Lewis - Morgan Stanley Daniel Leonard - W ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q HOLOGIC, INC. (Exact name of registrant as specified in its charter) __________________________________________________________ or Massachusetts 01752 Delaware 04-2902449 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 250 Campus Drive, Marlborough, (Mark One) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE ...

Hologic, Inc. (NASDAQ:HOLX) Q1 2020 Earnings Conference Call January 29, 2020 4:30 PM ET Company Participants Michael Watts - VP, IR & Corporate Communications Stephen MacMillan - Chairman, CEO & President Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citigroup Chris Lin - Cowen and Company Tycho Peterson - JPMorgan Chase & Co. Jack Meehan - Barclays Bank Rachel Vatnsdal - Piper Sandler & Co. Brian Weinstein - William Blair & Company David Lewis - Morgan Stanley Rajbir Denhoy - Jeffe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 28, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to HOLOGIC, INC. (Exact name of registrant as specified in its charter) ________________________ ...

Reintroducing a Unique Asset in Women's Health Steve MacMillan Chairman, President and CEO 38th Annual J.P. Morgan Healthcare Conference January 13, 2020 1 Safe Harbor Statement This presentation contains forward-looking information that involves risks and uncertainties, including statements about the Company's plans, objectives, expectations and intentions. Such statements include, without limitation: financial or other information based upon or otherwise incorporating judgments or estimates relating to fu ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 28, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 _________________________________________________ ...

Hologic, Inc. (NASDAQ:HOLX) Q4 2019 Results Conference Call November 6, 2019 4:30 PM ET Company Participants Mike Watts - Vice President of Investor Relations and Corporate Communications Steve MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Tycho Peterson - JPMorgan Bill Quirk - Piper Jaffray Jack Meehan - Barclays Ivy Ma - Bank of America Merrill Lynch Chris Lin - Cowen Mason Austen - Morgan Stanley Anthony Petrone - Jeffer ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 29, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HOLOGI ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q (Mark One) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 30, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ Holog ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q Hologic, Inc. (Mark One) (Exact name of registrant as specified in its charter) __________________________________________________________ (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 250 Campus Drive, Marlborough, Massachusetts 01752 (Address of principal executive offices) (Zip Code) Delaware 04-2902449 ý QUARTER ...